Charles Esdaile says 5,000,000–7,000,000 died overall, including civilians.  These numbers are subject to considerable variation. Erik Durschmied , in his book The Hinge Factor , gives a figure of million French military deaths of all causes. Adam Zamoyski estimates that around 400,000 Russian soldiers died in the 1812 campaign alone—a figure backed up by other sources. [ who? ] Civilian casualties in the 1812 campaign were probably comparable. Alan Schom estimates some 3 million military deaths in the Napoleonic wars and this figure, once again, is supported elsewhere. [ where? ] Common estimates of more than 500,000 French dead in Russia in 1812 and 250,000–300,000 French dead in Iberia between 1808 and 1814 give a total of at least 750,000, and to this must be added hundreds of thousands of more French dead in other campaigns—probably around 150,000 to 200,000 French dead in the German campaign of 1813 , for example. Thus, it is fair to say that the estimates above are highly conservative. [ citation needed ]
Landrigan also expressed concern about the Trump administration's stated plans to roll back environmental protections designed to reduce air and water pollution with the aim of promoting industrial growth: "It has been 47 years since we passed the Clean Air Act in 1970, and in that time we have reduced air pollution in this country by 70% and at the same time our Gross National Product grew by 250%. These data put the lie to the claims that controlling pollution kills jobs, hurts the economy, and stifles economic growth. It simply isn't true."
Until now, the medical device has been the subject of controversy for a different reason. EpiPen is sold by Mylan NV, a drugmaker legally based in the Netherlands but run from Pennsylvania, that was under fire last year for significantly raising the price of the allergy shot, from about $50 for a single pen to more than $600 for a two-pack. Congress held hearings, government agencies began inquiries, and rival Sanofi sued. The Paris-based competitor claimed Mylan sought ‘to preserve the monopoly position of their $1 billion crown jewel’ by engaging in anti-competitive conduct. Mylan has denied any wrongdoing.